Consumer Price Index Rises 38 Annually in April Exceeding Expectations and Marking Highest Level Since May 2023 Companies Continue to Expand Prediction Market Investments Amid Regulatory Uncertainty Quantum Computing Stocks Surge as US Unveils 2 Billion Funding Plan for Nine Firms SP 500 Edges Higher as Healthcare and Technology Lead Communication Services Lags ExBankers Command 25000 Per Day to Train Wall Street on AI Supermarkets Resist Calls for Mandatory Price Caps on Milk Bread and Eggs as Government Confirms Talks KOF Q1 2026 Earnings EPS Misses Estimates Amid Challenging Operating Environment ARCB Q1 2026 Earnings EPS Surprise of 1536 Drives Stock Higher HUN Q1 2026 Earnings NarrowerthanExpected Loss Amidst Challenging Chemical Markets NTWK Q1 2026 Earnings Positive Profitability Trends Amid Transformational Growth FRME Q1 2026 Earnings EPS Beats Estimates by Nearly 9 as Stock Edges Lower Voyager Therapeutics Inc VYGR Q1 2026 Earnings Narrowed Loss and Pipeline Progress Support Positive Market Reaction MVSTW Warrants Continue to Trade at Penny Levels Amid Minimal Price Action Malibu Boats MBUU Slides 15 as Stock Tests Key Support Zone MBIA Inc MBI Edges Higher Amid Steady Trading as Shares Test Key Resistance Blueport Acquisition BPAC Edges Higher Near Resistance A Test of Momentum Roboai Inc AIIO Plunges 17 as Investor Sentiment Sours Approaches Key Support NFL Seeks to Ban MicroBetting Contracts and Injury Wagers from Prediction Markets SERV Q1 2026 Earnings WiderThanExpected Loss Amid EarlyStage Robotics Progress NMP Acquisition Corp NMP Holds Steady Near Support as SPAC Trading Remains Tepid VVX Q1 2026 Earnings Strong EPS Beat of 475 Surprises Market Exodus Movement Inc EXOD Q1 2026 Earnings Large EPS Miss Overshadowed by Positive Stock Reaction EVI Industries Q1 2026 Earnings EPS Miss Weighs on Shares Revenue Details Not Disclosed VOXR Q1 2026 Earnings Massive EPS Surprise Drives Interest Yet Stock Falters ACET Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Response Acrivon Therapeutics Q1 2026 Earnings Narrowerthanexpected loss as clinical development progresses IT Q1 2026 Earnings Strong EPS Beat Bolsters Investor Confidence